The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
Cleveland Diagnostics said Monday it received Food and Drug Administration approval for a test that analyzes the structure of protein biomarkers in the blood for prostate cancer signals, to aid in ...
Cofounding CEO Arnon Chait to remain with company as Chief Innovation Officer Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, has named Michael Iskra as its new ...
Everyday Health on MSN
The latest at-home cancer screening tests to know about
These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.
The National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-has published a new book explaining ...
CINCINNATI, March 19, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (ONCO), (“Onconetix” or the “Company”), (formerly Blue Water Biotech, Inc. (BWV)), a cancer ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. This voice experience is generated by AI. Learn more. This voice ...
Add Yahoo as a preferred source to see more of our stories on Google. A young person is undergoing a diagnostic medical imaging procedure. “We believe in screening so deeply because psychologically, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results